Nutriband Inc. Common Stock
Market Cap
43M
Short interest (May 15)
1.5%
Net Short (Jun 03 ): 0.0%
Borrow Fee
2.03%
↓ 44.7%
Available Shares
300K
↑ 42.9%
Price Chart
Company Overview
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.